Equine Veterinary Journal

Cover image for Vol. 46 Issue 3

Edited By: Celia M. Marr

Impact Factor: 2.286

ISI Journal Citation Reports © Ranking: 2012: 8/143 (Veterinary Sciences)

Online ISSN: 2042-3306

Associated Title(s): Equine Veterinary Education



Author Guidelines


Author Guidelines

Content of Author Guidelines: 1.General Introduction, 2. Ethical Guidelines, 3. Manuscript Types Accepted, 4. Manuscript Format and Structure, 5. Submission of Manuscripts, 6. After Acceptance, 7. Pre-Submission Checklist

Useful Websites: Submission Site, Articles published in Equine Veterinary Journal, Author Services, Wiley Blackwell Publishing's Ethical Guidelines, Guidelines for Figures

EQUINE VETERINARY JOURNAL

AUTHOR GUIDELINES

1. GENERAL INTRODUCTION

Equine Veterinary Journal (EVJ) publishes and promotes high quality peer-reviewed research that expands the knowledge base about equids, informs veterinary science and improves clinical practice. This unrivalled international scientific journal is published 6 times per year with around 128 pages per issue, containing articles with original and potentially important findings. Contributions are received from sources worldwide.

EVJ publishes original articles and reviews on all aspects of equine veterinary science. Categories include General Articles, Short Communications, Technical Notes, Retrospective Case Series and Case Reports, Review Articles and Correspondence (see Section 3). They present new developments in research being carried out both by researchers in institutes and from clinicians in practice devoted to all aspects of equine and/or comparative veterinary sciences.

Original Manuscripts first undergo an Internal Editorial Assessment to ensure that the manuscript content is of interest to our readership and the manuscript format and quality conforms to our guidelines described below. If deemed appropriate, manuscripts are then assessed by at least two external peer reviewers and our review process is double-blinded (i.e. the reviewers are not identified to the authors and vice versa, see Marr, C.M. (2011) Masking the peer review process: better or worse? Equine Vet J, 43, 249). Many manuscripts also undergo assessment by an individual with expertise in study design and data analysis. Our median time for completing the review process for original submission is around 5 weeks. Accepted manuscripts are pre-published and submitted for indexing within a few days of acceptance.

Please read the instructions below carefully for details on format and submission of manuscripts, the journal’s requirements and standards as well as for information concerning the procedure after a manuscript has been accepted for publication in EVJ. Authors are encouraged to visit Wiley Blackwell Publishing’s Author Services for further information on the preparation and submission of articles and figures.

2. ETHICAL GUIDELINES

2.1 Previous publications

Authors submitting an article do so with the understanding that the work and its essential substance have not been published in full before and is not being considered for publication elsewhere. If abstracts have been published, in print or online, full papers will be considered only if the published abstract was less than 1000 words and did not contain figures or tables. A copy of the abstract should be uploaded to ScholarOne at the time of submission as a supporting file (see Section 5.4). EVJ accepts material that has been presented orally at conferences that include web-based distribution of video or audio recording of presentations. Manuscripts are screened with software designed to detect plagiarism.

2.2 Authorship

EVJ adheres to the definition of authorship set up by The International Committee of Medical Journal Editors (ICMJE). According to the ICMJE, authorship criteria should be based on 1) substantial contributions to conception and design of, or acquisition of data or analysis and interpretation of data, 2) drafting the article or revising it critically for important intellectual content and 3) final approval of the version to be published. Authors should meet conditions 1, 2 and 3. Except in the case of complex large-scale or multi-centre research, the number of authors should normally not exceed six. Corresponding authors should ensure that all authors are entered as co-authors when uploading the manuscript to ScholarOne. A statement of each author’s contribution to study design, data collection and study execution, data analysis and interpretation, and preparation of the manuscript will be published. Contributors who do not qualify as authors should be mentioned under Acknowledgements.

2.3. Use of animals in research

Manuscripts will be considered for publication only if the work detailed therein:

o Follows international, national, and/or institutional guidelines for humane animal treatment and complies with relevant legislation in the country in which the study was conducted;
o For studies using client-owned animals, demonstrates a high standard (best practice) of veterinary care and involves informed client consent;
o Has been approved by the ethics review committee at the institution, hospital or practice at which the studies were conducted where such a committee exists;
o Where such a committee does not exist, authors are expected to have their research in a manner likely to be approved by ethics committees in most countries.

Submissions must be accompanied by a statement, in our submission form, certifying that legal and ethical requirements have been met with regards to the humane treatment of animals described in the study and specifying the ethical review committee that has overseen this process and/or the international, national and/or institutional guidelines followed. This information will be included in the Declarations Section. Please also include this information under the separate heading of "Ethical Considerations" in the “Title page” document (see Section 4.2).

When research animals are used, the methods section must clearly indicate that adequate measures were taken to monitor and address the welfare of the animals involved. Editors reserve the right to reject papers if there is doubt as to whether appropriate procedures have been used and also to insist that information is provided in the text as to the measures taken to protect the welfare of subjects and the outcome of procedures undertaken in respect to any pain or suffering caused.

2.4 Antimicrobial Stewardship Policy

Authors should consider WHO’s risk management strategies for the containment of antimicrobial resistance in humans due to non-human use of antimicrobials. In particular, where quinolones, extended spectrum beta-lactam antimicrobials (such as 3rd/4th generation cephalosporins) or macrolides not labelled for use in horses in the country from which the report originates have been used as part of the treatment regimen, or are being evaluated for potential use in equine patients, the reasons underlying these choices must be robustly defended. Information on Critically Important Antimicrobials for Human Medicine can be found here. Further discussion of EVJ’s Antimicrobial Stewardship Policy can be found in Bowen, Equine Veterinary Journal, Volume 45, Issue 2, 127-129.

EVJ’s Antimicrobial Stewardship policy is, in part, a self-certifying process. In many clinical studies, for example those describing large retrospective series relating to surgical procedures, it may not be necessary or appropriate to list extensive details of antimicrobials given to the horses in the study. At the time of submission, authors will be asked if Critically Important Antimicrobials have been used and will be expected to discuss and justify their use explicitly. Where Critically Important Antimicrobials have not been used, it is often appropriate to include statements such as “horses were given perioperative antimicrobials” without expanding further.

2.5 Competing Interests

Authors are required to disclose any competing interests. These include financial interests (for example patent, ownership, stock ownership, consultancies, speaker’s fee). Employment with commercial companies whose products are used in the study should be stated and intention to apply for a patent by an individual or company in any way related to the authors must be declared. If the author does not include a competing interest statement in the submission form, then the following statement will be included by default: “The authors have declared no competing interests”. Please also include this information under the separate heading of "competing interests" in the “Title page” document (see Section 4.2).

2.6 Source of Funding

Authors are required to specify the source of institutional, private and corporate financial support for their research when submitting a paper. Please include this information under the separate heading of "Source of Funding" in the ”Title page” document (see Section 4.2).

2.7 Permissions

If all or parts of previously published illustrations are used, permission must be obtained from the copyright holder concerned. It is the author’s responsibility to obtain these in writing and provide copies to the Publishers. If material is used that has been published elsewhere or is given as a personal communication, it is the author’s responsibility to obtain permission from the publisher and author.

2.8 Appeal of Decision

Authors who wish to appeal the Editors’ decision on their submitted manuscript may do so by e-mailing Editor@evj.co.uk with a detailed explanation of their rationale for appealing the decision.

2.9 Copyright Assignment

The submission of the manuscript by the authors means that the authors agree to sign a Copyright Transfer Agreement form when the manuscript is accepted for publication. When the manuscript is accepted for publication, the copyright becomes the property of EVJ Ltd.

If your paper is accepted, the author identified as the formal corresponding author for the paper will receive an email prompting them to login into Author Services; where via the Wiley Author Licensing Service (WALS) they will be able to complete the license agreement on behalf of all authors on the paper.

For authors signing the copyright transfer agreement: If the OnlineOpen option is not selected the corresponding author will be presented with the copyright transfer agreement (CTA) to sign. Please ensure you read the details of the copyright agreement thoroughly and carefully to ensure that you are able to fully comply with the terms. The terms and conditions can be previewed in the sample associated with the copyright FAQs below:

CTA terms and conditions http://authorservices.wiley.com/bauthor/faqs_copyright.asp. In section 8 you will find samples of the CTA. EVJ uses CTA-A.

For authors choosing OnlineOpen: If the OnlineOpen option is selected the corresponding author will have a choice of the following Creative Commons License Open Access Agreements (OAA):

Creative Commons Attribution License OAA

Creative Commons Attribution Non-Commercial License OAA

Creative Commons Attribution Non-Commercial -NoDerivs License OAA

To preview the terms and conditions of these open access agreements please visit the Copyright FAQs hosted on Wiley Author Services http://authorservices.wiley.com/bauthor/faqs_copyright.asp and visit http://www.wileyopenaccess.com/details/content/12f25db4c87/Copyright--License.html

If you select the OnlineOpen option and your research is funded by The Wellcome Trust and members of the Research Councils UK (RCUK) you will be given the opportunity to publish your article under a CC-BY license supporting you in complying with Wellcome Trust and Research Councils UK requirements. For more information on this policy and the Journal’s compliant self-archiving policy please visit: http://www.wiley.com/go/funderstatement

3. MANUSCRIPT TYPES ACCEPTED

Authors are encouraged to consult Wiley’s Free Online Guide: Writing for Publication in Veterinary Medicine.

3.1 General Articles

General Articles should describe experimental or clinical research studies, including systematic reviews, and normally be around 4000 words including figure legends, table legends and references, with up to 3 tables and 6 figures. Each figure can consist of 4 sub-panels. Figures must be selected carefully and each must enhance the article. Our reviewers and editors will assess the value of each and where individual figures are not considered essential they may be deleted or moved to online only. In all but exceptional circumstances, we are unlikely to publish 6 x 4 sub-panels in print. Our typesetters may choose to set out larger and composite figures across 2 columns but the author must consider the size of the resultant print images particularly where diagnostic images are included in sub-panels. The maximum width of the sub-panels will be 42 mm, with 2 images across each column.

A summary, no more than 300 words in total, should be provided with the following headings.

Reasons for performing study: i.e. why the work was undertaken in the first place, the background behind the decision to choose this subject to study.
Objectives: The statement that is being tested, and is testable by the methods (below); or the original aims of the study and the deliverables.
Study Design: concise statement of the study design.
Methods: Brief description of materials and methods and methods of testing hypotheses.
Results: Brief highlights of the results obtained.
Conclusions: Conclusions drawn from results.

The introduction should be limited to 500 words. The introduction should be a succinct (approximately two paragraphs), conveying why the subject is important and briefly describing what information is known. Do not provide a comprehensive review of the literature but do state clearly the rationale for your study along with your hypothesis or research question and specific objectives. Add a sentence summarising how your approach will help fill the gaps in information previously stated. Do not summarise the study findings here and avoid using excessive numbers of references to generally accepted introductory statements.

The remainder of the manuscript should be presented in the following sections; Materials and Methods, Results, and Discussion, with subheadings, including data analysis, as appropriate. Manuscripts exceeding 5000 words will not be sent to external peer reviewers. Additional tables, figures, video material or text describing further details of methods or results can be submitted as Supporting Information Items (see below). Where questionnaires or other similar instruments have been used to collect data a copy of this must be included for online publication. All quantitative results should be analysed by appropriate statistical methods.

To minimise publication bias, EVJ encourages authors to publish negative results, providing authors can demonstrate that the study had adequate power to detect differences.

Pairs or larger sets of papers that must be reviewed, and subsequently read, together are not accepted and articles must describe discrete studies, using references where appropriate to make methods sections concise. If appropriate, authors can upload in press articles with identifying details removed, for reviewers’ use.

Prior to submission of reports of studies involving experimental animals, authors are recommended to consult:

ARRIVE guidelines: http://www.nc3rs.org.uk/page.asp?id=1357

Prior to submission of reports of epidemiological studies, authors are recommended to consult:

Von Elm, E, Altman, D.G., Egger, M., Pocock, S.J. Gotzsche, P.C., Vandenbroueke, J.P. and STROBE Initiative (2007) Strengthening the reporting of observational studies in epidemiology (STROBE) statement: Guidelines for reporting observational studies. Br. Med. J. 335, 806-808.

Boden, L.A. and Parkin, T.D.H. (2008) Current guidelines on good reporting of analytical observational studies in epidemiology. Equine Vet J 40, 84-86. http://onlinelibrary.wiley.com/doi/10.2746/042516408X255927/abstract

Woolhouse, M.E.J., Fèvre, E.M., Handel, I., Heller, J., Tildesley, M.J., Parkin, T. and Reid, S.W.J. (2011) Guide to Good Practice for Quantitative Veterinary Epidemiology. http://www.qve-goodpracticeguide.org.uk/

Prior to submission of reports of clinical studies, authors are recommended to consult:

Altman, D.G. (1996) Better reporting of randomised controlled trials: the CONSORT statement. Br. Med. J. 313, 570-571.

Also at: http://www.consort-statement.org/

Sargeant, J.M., O'Connor, A.M., Gardner, I.A., Dickson, J.S., Torrence, M.E., Dohoo, I.R., Lefebvre, S.L., Morley, P.S., Ramirez, A. and Snedeker, K. (2010) The REFLECT Statement: Reporting guidelines for randomized controlled trials in livestock and food safety: Explanation and elaboration. J Food Prot. 73, 579-603.

Also at: http://www.reflect-statement.org/statement/

Boden, L.A. (2011) Clinical studies utilising ordinal data: pitfalls in the analysis and interpretation of clinical grading systems. Equine Vet J 43, 383-387. http://onlinelibrary.wiley.com/doi/10.1111/j.2042-3306.2011.00414.x/abstract

Prior to submission of reports of studies of diagnostic accuracy, authors are recommended to consult:

Bossuyt, P.M., Reitsma, J.B., Bruns, D.E., Gatsonis, C.A., Glasziou, P.P., Irwig, L.M., Lijmer, J.G., Moher, D., Rennie, D. de Vet, H.C.W., for the STARD steering group (2003) Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Br. Med. J. 326, 41.1. doi: http://dx.doi.org/10.1136/bmj.326.7379.41

Also at: http://www.stard-statement.org/

Prior to submission of reports of genetic prediction studies, authors are recommended to consult:

Janssens, A.C.J.W., Ioannidis, J.P.A., Renhborg, C.F., van Duijn, C.M., Little, J. Khoury, M.J. (2011) Strengthening the resporting of genetic risk prediction studies: the GRIPS statement. Br. Med. J. 342, d631. doi: http://dx.doi.org/10.1136/bmj.d631

Prior to submission of reports of economic evaluations, authors are recommended to consult:

Husereau, D., Drummond, M., Petrou, S., Carswell, C., Moher, D., Greenberg, D., Augustovski, F., Briggs, A.H., Mauskopf, J. and Loder, E. (2013) Consolidated health economics evaluation reporting standards (CHEERS) statement. Br. Med. J. 346, f1049. doi: http://dx.doi.org/10.1136/bmj.f1049

Prior to submission of reports of systematic review and/or meta-analysis, authors are recommended to consult:

The PRISMA Statement: http://www.prisma-statement.org/

Stroup, D.F., Berlin, J.A.., Morton, S.C., Olkin, I., Williamson, G.D., Rennie, D., Moher, D., Becker, B.J., Sipe, T.A. and Thacker, S.B. (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283, 2009-2010.

Additionally, although no substitute for obtaining advice on study design and data analysis at the time of planning their work, prior to submission authors should as far as possible address and include the points in the following checklist:

Clinical research studies should:

• Address a clearly defined clinical question.
• Describe a study, based on naturally occurring disease that provides strong clinical evidence to define outcomes relating to specific therapeutic or diagnostic interventions, and/or to refine prognostic indicators.
• Provide objective and unambiguous case definition criteria that are rigorously applied and explicitly reported.
• Evaluate clearly defined clinical outcomes that are rigorously applied and explicitly reported.
• Utilise and explicitly report the details of appropriate controls, randomisation and blinding as appropriate or feasible.
• Include a pre-study estimate of the power of the study to resolve a clinically useful difference (or other appropriate estimation of numbers required). For therapy or prevention trials, this power value should be 80% or more*. Authors are discouraged from conducting post hoc power calculations – interpretation of confidence intervals is preferred.
• Include a flow chart of subjects through each stage of eligibility, stating numbers agreeing to participate, randomisation, receiving the intervention in question, completing the study protocol and analysed for the study outcome. Retrospective studies should also include a flow chart to account for the numbers of animals eligible, recruited and used in the analysis.
• Include a flow chart of subjects through each stage of eligibility, stating numbers agreeing to participate, randomisation, receiving the intervention in question, completing the study protocol and analysed for the study outcome. Retrospective studies should also include a flow chart to account for the numbers of animals eligible, recruited and used in the analysis.
• Use appropriate analytical methods and report effect size estimates and the confidence intervals of any results*. Other measures of spread may be used in addition (including credible intervals), as appropriate. Confidence intervals estimated using standard deviation are appropriate for communication of variation in the population. The standard error should be used to estimate the confidence interval if the aim is to communicate the precision of a sample-based estimate or for inference.
• Confidence intervals should be used to express a plausible range in which the value of interest may lie (rather than just statistical significance). Authors should consider the clinical and/or biological relevance of the confidence limits as part of their interpretation of the results. Ideally, the values considered clinically/biologically significant should be determined a priori.
• P values, where used, should be presented to one significant figure (that is, the first non-zero number after the decimal place). The exceptions are P<0.001 and P>0.9, for very small and very large P values, respectively.
• Include manufacturer’s details for software used for statistical analysis.

*See Rossdale, P.D., Jeffcott, L.B. and Holmes, M.A. (2003) Clinical evidence: an avenue to evidence-based medicine. Equine Vet J 35, 634-635. http://onlinelibrary.wiley.com/doi/10.2746/042516403775696267/abstract

3.2 Case Reports and Retrospective Case Series

Larger retrospective case series should conform to the guidelines for General Articles. Smaller Case series (target word count 4000 words for up to 5-20 cases and up to 4 figures and 2 tables; 3000 words for 1-5 cases and up to 3 figures and 2 tables) with a short structured summary in our usual format (see Section 3.1), will normally be considered if their content addresses at least one of the following aims:

o Evidence of an hitherto unrecognised syndrome or disease.
o Evidence of emerging diseases in a previously unaffected country or region.
o Unreported or unusual side effects or adverse reactions involving medications, surgical or other veterinary procedures.
o Findings that shed new light on the possible pathogenesis of a disease.
o Findings that document a new diagnostic technique or novel application of existing technology.

Reports of novel treatments or invasive diagnostic techniques are unlikely to be considered unless a sufficiently large number of patients have been included to have reasonable insight in effectiveness and possible harms. Likewise, descriptions of congenital anomalies that have been well characterised in other species are unlikely to be of interest, except where the report fulfils other aims listed above. Authors should note that fewer than 10% of small case reports are accepted.

Prospective studies conforming to the guidelines for format for general articles will be included in “General Articles” section of the Journal.

3.3 Brief Reports

Two types of Brief Reports are considered:

3.3a Technical notes

A technical note is a short article giving a brief description of a specific development, technique or procedure, or it may describe a modification of an existing technique, procedure or device applicable to equine veterinary medicine (clinically or in a research setting). The technique, procedure or device described should have practical value and should contribute to clinical diagnosis or management, or be applicable in research. It could also present a software tool, or an experimental or computational method. The article must describe a demonstrable advance on what is currently available. The main criteria for publication will be the novelty of concepts involved, the validity of the technique and its potential for clinical or research applications. The method needs to have been well tested in terms of accuracy, repeatability and safety, and ideally, but not necessarily, used in a way that proves its value.

Technical notes should be around 2500 words in length and should contain no more than 2 figures and 2 tables, with a short structured summary in our usual format (see Section 3.1).

3.3b Short Communications

EVJ encourages authors to aim to complete substantial studies in order to produce a manuscript appropriate for a general article and the publishing of preliminary results is discouraged. Short Communications can be submitted to describe focused experimental or clinical research studies. This format is designed for publication of concise pieces of robust research that may not have enough volume of data for a standard manuscript but is still of stubstantial impact to the research and/or clinical community. To justify publication in the short communication format, the studies must be novel and well designed with appropriate data analysis. Studies reporting negative results (i.e. null hyopthesis cannot be rejected) will also be considered.

Short Communications should be around 2500 words in length and should contain no more than 2 figures and 2 tables, with a short structured summary in our usual format (see Section 3.1).

3.4 Review Articles

Review Articles are encouraged, however a preliminary discussion with the Editor regarding subject and length of the article is advisable before submission. Review Articles should normally address important topics relevant to equine veterinary medicine and synthesise results in areas in which there have been a large number of recent publications.

3.5 Correspondence

We encourage readers to write letters to the editor for publication. These should usually address one main theme and, if they relate to a specific EVJ article the authors of that article will automatically be given the opportunity to write a response. Appraisals of published work must be measured in tone and ideally supported with specific evidence of weaknesses in the study design, methods, analysis of data or conclusions drawn from the results. Correspondence on general issues important to equine veterinary medicine is also welcomed. Correspondence is peer reviewed by at least 2 individuals and normally these will be EVJ editors and/or members of our Editorial Consultant Board.

3.6 Editorial

EVJ’s editorial material is all commissioned and typically encompasses opinions on issues of current importance in equine veterinary sciences together with pieces expanding on studies published within the same EVJ issue. We are also interested in including reports of conferences and workshops and short overviews of work that has recently been published in basic science journals that may be of interest to EVJ readers. Editorials in these last two categories are usually described as “Science-in-brief”. Conference organisers and scientists wishing to draw readers’ attention to relevant basic science studies are encouraged to contact the Editor to discuss their suggestion (Editor@evj.co.uk). Editorial is not peer-reviewed but is assessed by one or more, EVJ editors prior to acceptance.

4. MANUSCRIPT FORMAT AND STRUCTURE (A checklist is available at Section 7).

4.1. Manuscript File Format

Manuscripts should be submitted as Word documents in double spacing on A4 page size, the pages should be numbered and there should be line numbers continuously throughout the document. Division of the paper should be indicated clearly by major headings, subheadings and sub-subheadings. Manuscript text must be uploaded as Word (.doc) (not write-protected).

The text file must contain the manuscript including summary, text, references, tables and figure legends but no embedded figures. Figure tags should be included in the file. A word count for the entire text including figure and table legends and references (but not including Supplementary Information) should be provided. Figures should be provided in separate files (see below for details of format).

4.2 Authors’ Identity and Declarations

Authors’ names, institutes, affiliations and declarations should not be included within the manuscript in order to facilitate double blinded review. To ensure the integrity of this process, authors must creat a separate Word document and upload this separately as the “Title page” document. This document should contain Ethical Considerations, Competing Interests, Sources of Funding, Acknowledgements and Authorship. Also list here any other details included in the Materials and Methods which might allow the reviewer to identify the authors or host institute, for example, hospital or ethical review committee names or reference to “in press” publications. In their place, within the main manuscript, state “masked for review” and highlight this. All such details must be included in the “Title Page” document, with reference to the appropriate line number. With all revisions, authors must re-insert such details into a clean, unblinded version of their manuscript that should be uploaded in addition to the blinded version with revisions marked. Copies of “in press” publications, with relevant identifying details removed, should be uploaded as “supporting information” for reviewers’ use.

4.3 Keywords for publication

Authors can provide up to six keywords for publication immediately below the title which may help readers find the article in various search engines. These should reflect the manuscript content and should usually include the word “horse” or similar but not “Equine” or “Veterinary” as these terms will be included in most Search Engines as being within the journal’s title. Keywords for publication should be listed within the “Title Page” document immediately below the authors’ names and addresses. Note during the submission process, you will also be required to choose ScholarOne keywords which facilitate the review process – see Section 5.6.

4.4 Language

The language of publication is English. Authors for whom English is a second language should consider having their manuscript professionally edited before submission to make sure the English is of high quality. A list of independent suppliers of editing services can be found at http://authorservices.wiley.com/bauthor/english_language.asp. All services are paid for and arranged by the author, and use of one of these services does not guarantee acceptance or preference for publication.

EVJ provides Chinese translations of selected article summaries online within the Supporting Information section. Authors are welcome to include foreign language translations of their summary as supplementary items for online only publication. Such items should be entitled “Supplementary Item: Summary in French” etc. If appropriate, start numbering any additional supplementary items from 1.

4.5 Abbreviations, Symbols and Nomenclature

Doses and measurements should be given in metric (SI) units with /kg bwt added where appropriate. Abbreviations are discouraged. Where possible, only abbreviations that are in common use within the relevant field or discipline should be used. Authors must avoid inventing their own abbreviations for anatomical terms and techniques. Where they are unavoidable, abbreviations must be explained in both the summary and main text. Spelling should conform to the Oxford English Dictionary, medical terminology to Dorlands Medical Dictionary and units, symbols and abbreviations should conform to the International System of Units defined by Baron, D.N. (Ed) (1994) “Units, Symbols, and Abbreviations: A Guide for Medical and Scientific Editors and Authors, 5th edn.” Royal Society of Medicine Press, London.

4.6 Drug names and Manufacturers’ details

The generic name of drugs, equipment or other materials should be given in the text, with product name in brackets. Recommended International Non-Proprietary Names (rINNs) should be used. The manufacturer’s details (company name, town/city, state/county and country) should then be listed under a “Manufacturers’ details” heading at the end of the article before the Reference section. References to this list should be indicated as superscript letters throughout the text. Brand or trade names should not be used in the title and must be in brackets throughout the text.

4.7 Optimising Your Article for Search Engines

Many students and researchers looking for information online will use search engines such as Google, Yahoo or similar. By optimising your article for search engines, you will increase the chance of someone finding it. This in turn will make it more likely to be viewed and/or cited in another work. We have compiled these guidelines to enable you to maximise the web-friendliness of the most public part of your article.

4.8 References

It is the responsibility of the authors to ensure that all reference details are accurate. References are indicated throughout the text as numbers within square brackets [1, 2, 3 etc] and the final list of references must correspond with the order in which they appear in the main body of the text.

The format in the reference list is as follows: author(s) name(s) and initials, year of publication in parentheses, full title of article, journal title (in italics) as abbreviated in the World List of Scientific Periodicals, volume number (in bold) and page numbers: e.g. Foster, B.W., Codd, J. and Smith, R. (1992) Effect of stress on ulcers in foals. Equine Vet J 35, 43-52.

References to book articles should be set out as follows: author(s) name(s) and initials, date of publication in parentheses, title of chapter or article, full title of book, edition, name(s) of editor(s) if relevant, publisher, place of publication and pages referred to: e.g. Robin, C. (1991) Calcium in plants eaten by horses. In: Dietary Calcium, 2nd edn., Ed: J. Chalk, Blackwells Scientific, London. pp 195-201.

The editor and publisher recommend that citation of online published papers and other material should be done via a DOI (digital object identifier), which all reputable online published material should have - see www.doi.org/ for more information. If an author cites work that does not have a DOI they run the risk of the cited material not being traceable. We recommend the use of a tool such as EndNote or Reference Manager for reference management and formatting. EndNote reference styles can be searched for here: www.endnote.com/support/enstyles.asp Reference Manager reference styles can be searched for here: www.refman.com/support/rmstyles.asp

4.9 Table and Figure Legends

Legends should be short as appropriate but should be intelligible to the reader without reference to the text. Legends should also cite references if appropriate. A list of figure legends should be placed at the end of the text (before references).

4.10 Tables

Tables should be referenced in the appropriate place in the text but should be placed at the end of the text (before references) accompanied by appropriate legends. Duplication of data in tables, figures and text must be avoided.

4.11 Figures

Illustrations should be provided when necessary to clarify the text. Figures should be referred to in the text. Authors are encouraged to use colour in graphs, line drawing and other figures.

Photomicrographs must state magnification, preferably with a scale bar, and staining technique. Line drawings should be original diagrams on clean white paper or board and must be submitted in digital form (see below). Symbols and lines should be standard and not drawn by hand. Do not include a “chart title” when creating graphs and charts.

Print publication requires high quality images to prevent the final product being blurred or fuzzy. Submit EPS (line art) or TIFF (halftone/photographs) files only. Do not use pixel-oriented programs. Scans (TIFF or JPG) should have a resolution of at least 300 dpi (halftone) or 600 to 1200 dpi (line drawings) in relation to the reproduction size (see below). EPS files should be saved with fonts embedded (and with a TIFF preview if possible). For scanned images, the scanning resolution (at final image size) should be as follows to ensure good reproduction: line art: >600 dpi; halftones (including gel photographs): >300 dpi; figures containing both halftone and line images: >600 dpi. Further information can be obtained at Wiley Blackwell Publishing’s guidelines for figures: http://www.authorservices.wiley.com/bauthor/illustration.asp Check your electronic artwork before submitting it: http://www.authorservices.wiley.com/bauthor/eachecklist.asp

4.12 Supplementary Information

Supplementary Information is material that is not essential, such as data sets or additional figures, tables or video files. It will not be published in the print edition of the journal, but will be viewable via the online edition. There is no limit to the number of supplementary items that can be included. Supplementary Information Items are subject to the peer review process and to ensure that the peer review process is blinded, it may be necessary for authors to upload 2 copies of some items, one of which is masked for peer review. Supplementary Information is material that is not essential to the article but provides greater depth and background. The items should be referred to in the main body of the text of the article where appropriate. The availability of Supplementary Information should be indicated in the main manuscript by a list, to appear after the References, headed "Supplementary Information Items" and providing titles of figures, tables, etc. See Section 5.4 for details of how to upload these files.

Items submitted for inclusion online as Supplementary Information do not undergo copyediting or typesetting, rather they appear largely as the authors have submitted them with minor corrections being made by the Editors only. Therefore, supplementary items are not sent back to authors at the proof correction stage.

Supplementary Information items must be prepared as follows:

1. Submit each item as a separate file.
2. Text: Word (.doc) only; A4, page set up portrait, double spaced, top and bottom margins 3.17 cm; left and right margins 2.54 cm, continuous line numbers, page numbers, font – Arial size 10.
3. Figures: GIF, TIFF, EPS, PNG, JPEG, BMP, PDF; labelling Arial font, with size selected as appropriate for figure.
4. Tables: Word (.doc) only; A4, Page set up can be as portrait or landscape as appropriate; top and bottom margins 3.17 cm; left and right margins 2.54 cm, continuous line numbers, page numbers, font – Arial, size as appropriate.
5. Movies: MPEG, AVI or quicktime movie format. Any labelling should be should be in Arial font, with size selected as appropriate. Several small clips are preferable to one large movie.
6. The maximum size of each individual supplementary item is 5Mb.

5. SUBMISSION OF MANUSCRIPTS

5.1 ScholarOne Manuscripts

EVJ uses ScholarOne Manuscripts for online manuscript submission and peer review found at http://mc.manuscriptcentral.com/evj. Full instructions and support are available on the site and a user ID and password can be obtained on the first visit. If you require assistance then click the Get Help Now link that appears at the top right of every ScholarOne Manuscripts page.

5.2 Covering Letter

Submissions should include a covering letter stating that the paper is original, has not been submitted or published elsewhere, and has the approval of all authors.

5.3 Submission Fee

There is a submission fee of £62.00 for every paper that goes through the peer review process. When a manuscript has been submitted to EVJ via ScholarOne, the corresponding author will receive an email with a submission fee form attached. The form can be filled in with credit card details and returned to the Editorial Office. If you prefer to pay by another method contact our Editorial Office (jane@evj.co.uk). This fee is waived if, during the Internal Editorial Assessment, it is decided the paper will not undergo further peer review.

5.4 Submission Process

To allow double-blinded review, please upload your manuscript in the following manner:

1. Title page (including authors’ names and affiliations, corresponding author’s email address, keywords for publication, acknowledgements, conflicts of interest, source(s) of funding, word count and any details “masked for review”) should be uploaded under the file designation “Title Page”. Documents uploaded as “Title Page” will not be viewable in the HTML and PDF format you are asked to review at the end of the submission process.
2. Your manuscript, without a title page, under the file designation “Main Document”
3. Figure files under the file designation “Figure”
4. Tables under the file designation “Table”
5. Supplementary items under the file designation “Files for online publication only”
6. Supporting information (e.g. copies of previously published abstracts or “in press” publications, with identifying information removed for use by editors and reviewers) under the file designation “Supporting Information”

5.5 Suggesting a Reviewer

In order to facilitate the review process, EVJ is prepared to receive suggestions from authors as to appropriate peer reviewers (with e-mail addresses) but these will be followed at the editors’ discretion.

5.6 ScholarOne Keywords

During the submission process, you will be required to select keywords describing the discipline(s) and body system/disease(s) that most closely relate to the content of your article from prescribed lists. These are used by the Editorial Office to match your article with appropriate reviewers. Note: these words can also be used as the “Keywords for Publication”, but this is not obligatory – see Section 4.3.

5.7 Suspension of Submission Mid-way in the Submission Process

You may suspend a submission at any phase before clicking the "Submit" button and save it to submit later. The manuscript can then be located under "Unsubmitted Manuscripts" and you can click on "Continue Submission" to continue your submission when you choose to.

5.8 Confirmation of Submission

After submission you will receive an e-mail to confirm receipt of your manuscript. If you do not receive the confirmation e-mail after 24 hours, please check your e-mail address carefully in the system. If the e-mail address is correct, please contact your IT department. The error may be caused by spam filtering software on your e-mail server. Also, the e-mails should be received if the IT department adds our e-mail server (uranus.scholarone.com) to their whitelist.

5.9 Manuscript Status

You can access ScholarOne at any time to check your "Author Centre" for the status of your manuscript. The Journal will inform you by e-mail once a decision has been made.

5.10 Submission of Revised Manuscripts

Revised manuscripts must be uploaded within 12 weeks of authors being notified that they are invited to submit a revision. Locate your manuscript under "Revised Manuscripts in Draft" and click on "Continue Submission" to submit your revised manuscript. If, however, it is not possible to resubmit within this time frame, please contact the Editorial Office (jane@evj.co.uk). It is essential that you provide a point-by-point response to each of the reviewers’ comments.

All revised articles must be uploaded with:
(i) a main document containing a version which does not have a title page and is blinded and in which all changes are highlighted using 'track changes' mode. This version will be sent out to reviewers.

(ii) a document containing a version which includes the title page and in which blinding details have been re-inserted and changes are not marked. This should be uploaded with the file designation 'Clean Non-Blinded Copy'. If your manuscript is accepted, this version will be uploaded to our Accepted Articles section.

6. AFTER ACCEPTANCE

6.1 Pre-publishing of Accepted Articles

EVJ pre-publishes accepted articles online within a few days of acceptance. This service is not available with editorial material or for some supplements. Accepted articles are given a Digital Object Identifier (DOI), which allows the article to be cited and tracked before it is allocated to an issue. After print publication, the DOI remains valid and can continue to be used to cite and access the article. Information about accepted articles is submitted to indexing services as soon as they appear online.

6.2 Author Services

Online production tracking is available for your article through Wiley Blackwell’s Author Services. Author Services enables authors to track their article, once it has been accepted, through the production process to publication online and in print. Authors can check the status of their articles online and choose to receive automated e-mails at key stages of production. The author will receive a unique link that enables them to register and have their article automatically added to the system. Please ensure that a complete e-mail address is provided when submitting the manuscript. Visit http://www.authorservices.wiley.com/bauthor/eachecklist.asp for more details on online production tracking and for a wealth of resources including FAQs and tips on article preparation, submission and more. For more substantial information on the services provided for authors, please see Wiley Blackwell Publishing Author Services.

6.3 Proof Corrections

The corresponding author will receive an e-mail alert containing a link to a website. The proof can be downloaded as a PDF (portable document format) file from this site.

Acrobat Reader will be required in order to read this file (www.adobe.com/products/acrobat/readstep2.html). In your absence, please arrange for a colleague to access your e-mail to retrieve the proofs. Proofs must be returned to the Wiley Blackwell Production Editor within three days of receipt.

As changes to proofs are costly, we ask that you only correct typesetting errors. Please note that the author is responsible for all statements made in their work, including changes made during the editorial process and thus you must check your proofs carefully.

6.4 EarlyView (Online Publication Prior to Print)

EarlyView articles are complete full-text articles published online in advance of their publication in a printed issue. EarlyView articles are the version of record and are complete and final. They have been fully reviewed, revised and edited for publication, and the authors’ final corrections have been incorporated. As they are in final form, no changes can be made after online publication. EarlyView articles are given a Digital Object Identifier (DOI), which allows the article to be cited and tracked before it is allocated to an issue. After print publication, the DOI remains valid and can continue to be used to cite and access the article.

6.5 Author Material Archive Policy

Please note that unless specifically requested, Wiley Blackwell Publishing will dispose of all hardcopy or electronic material submitted two months after publication. If you require the return of any material submitted, please inform the editorial office or production editor as soon as possible.

6.6 Offprints and Extra Copies

A PDF offprint of the online published article will be provided free of charge to the corresponding author, and may only be distributed subject to the Publisher’s terms and conditions, as described in the the Copyright Transfer Agreement. Additional paper offprints may be ordered online. Please click on the following link, fill in the necessary details and ensure that you type information in all of the required fields: offprint.cosprinters.com/cos/bw/main.jsp?SITE_ID=bw&FID=USER_HOME_PG. If you have queries about offprints please e-mail offprint@cosprinters.com

7. PRE-SUBMISSION CHECK LIST FOR MANUSCRIPT FORMAT AND STRUCTURE

A checklist to help you ensure your manuscript is ready for submission is available to download here (PDF file).

SEARCH

SEARCH BY CITATION